Alignment Healthcare, Inc. (ALHC) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Alignment Healthcare, Inc. operates as a consumer-centric Medicare Advantage platform serving seniors across California, North Carolina, Nevada, Arizona, and Texas. As of June 30, 2026, the company reported 294,100 Health Plan Members, representing a 31.5% increase year-over-year. The company operates as a single reportable segment focused on providing healthcare services to seniors.
Key Financial Metrics
| Metric (in thousands) | Q2 2026 | Q2 2025 | 6 Months 2026 | 6 Months 2025 |
|---|---|---|---|---|
| Total Revenues | $1,335,633 | $1,015,288 | $2,570,830 | $1,942,220 |
| Net Income | $36,560 | $15,653 | $47,976 | $6,299 |
| Income from Operations | $42,100 | $22,748 | $57,603 | $17,355 |
| Medical Benefits Ratio (MBR) | 86.3% | 86.7% | 87.2% | 87.5% |
| Adjusted EBITDA | $68,145 | $45,913 | $105,996 | $66,091 |
| Cash and Cash Equivalents | $693,453 | $470,266 | $693,453 | $470,266 |
| Long-Term Debt (Net) | $324,056 | $323,176 | $324,056 | $323,176 |
Note: MBR is calculated as medical expenses (excluding depreciation and equity-based compensation) divided by total revenues.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 31.6% in Q2 2026 and 32.4% for the six months ended June 30, 2026, primarily driven by a 31.5% increase in Health Plan membership.
- Profitability Expansion: Net income attributable to the company surged 133.6% in Q2 and 661.6% for the six-month period compared to 2025. Operating income grew 85.1% in Q2.
- Expense Management: Medical expenses increased 31.0% in Q2, tracking closely with membership growth. Selling, general, and administrative (SG&A) expenses increased 26.2% in Q2 but decreased as a percentage of revenue from 10.2% to 9.8% due to economies of scale.
- Cash Flow: Net cash provided by operating activities for the six months ended June 30, 2026, was $111.4 million, a significant increase from $45.7 million in the prior year period.
- Debt Structure: The company entered into a new $200 million senior secured revolving credit facility in February 2026. As of June 30, 2026, there were no borrowings under this facility. The company also holds $330 million in 4.25% Convertible Senior Notes maturing in 2029.
Guidance, Outlook, and Risks
Management Commentary: Management attributes strong performance to the "Care Anywhere" clinical model and the AVA technology platform, which allow for personalized care and cost control. The company maintains a 4-star or higher CMS rating for 100% of its health plan members. Management expects to continue investing in technology, sales, and marketing to drive growth.
Outlook: The company anticipates seasonal variability, with significant member growth typically occurring in Q1 following the annual enrollment period. Per-member revenue often declines as the year progresses due to new member risk-adjustment scores and senior mortality impacts on high-acuity members.
Risks and Contingencies:
- Regulatory Audits: The company is undergoing a Risk Adjustment Data Validation (RADV) audit for its California HMO plan regarding payment year 2019. CMS has expanded RADV audits, which could result in retrospective payment adjustments.
- Legal Proceedings: A former executive officer filed a whistleblower lawsuit on July 7, 2026, alleging retaliation and accounting irregularities. The company intends to defend vigorously and has not accrued a liability.
- Capital Requirements: While the company believes current cash flows are sufficient for the next 12 months, future growth and acquisitions may require additional equity or debt financing.
- Interest Rate Risk: The new revolving credit facility exposes the company to floating interest rate risks based on SOFR.
Investor Verification Checklist
- Membership Quality: Verify the retention rates of new members versus existing cohorts to assess the sustainability of the improving Medical Benefits Ratio (MBR).
- RADV Audit Impact: Monitor the outcome of the 2019 RADV audit and potential financial exposure from CMS extrapolation methodologies.
- Debt Covenants: Confirm continued compliance with the new Revolving Credit Facility covenants, specifically the minimum Consolidated EBITDA requirements ($60M for Q2 2026).
- Legal Exposure: Track the status of the whistleblower lawsuit filed in July 2026 for potential financial or reputational impact.
- Capital Allocation: Review future capital expenditure plans regarding the AVA platform and potential acquisitions to ensure liquidity remains adequate.